Register Now

Forgotten Password?

Distribution and marketing agreement for products

Companies: Pfizer
Shanghai Pharmaceutical
Announcement date: Apr 20 2011
Deal value, US$m: n/d

Details

Announcement date: Apr 20 2011
Industry sectors: Bigpharma
Pharmaceutical
Deal components: Distribution
Marketing
Stages of development: Marketed
Geographic focus: Asia » China

Financials

Deal value, US$m: n/d

Termsheet

Pfizer have signed a memorandum of understanding to explore a broad range of mutual projects in China.

The immediate goal is to give Shanghai Pharma the responsibility for registering and marketing an unspecified innovative Pfizer drug.

MOU envisions deepening the relationship between the two companies, including possible equity investments.

Press Release

Shanghai Pharma and Pfizer Sign MOU to Expand Collaboration

publication date: Apr 21, 2011

Shanghai Pharmaceutical and Pfizer have signed a memorandum of understanding to explore a broad range of mutual projects in China. The immediate goal is to give Shanghai Pharma the responsibility for registering and marketing an unspecified innovative Pfizer drug. But the MOU envisions deepening the relationship between the two companies, including possible equity investments.

Filing Data

Not available.

Contract

Not available.